Secondary Hyperparathyroidism in a Patient with CKD
- PMID: 32461217
- PMCID: PMC7341786
- DOI: 10.2215/CJN.13411119
Secondary Hyperparathyroidism in a Patient with CKD
Keywords: CKD; Chronic; Hyperparathyroidism; Renal Insufficiency; Secondary; parathyroid hormone.
Figures
References
-
- Sprague SM, Crawford PW, Melnick J, Strugnell SA, Ali S, Mangoo-Karim R, Lee S, Petkovich PM, Bishop CW: Use of extended-release calcifediol to treat secondary hyperparathyroidism in stages 3 and 4 chronic kidney disease. Am J Nephrol 44: 316–325, 2016. - PubMed
-
- Cunningham J, Locatelli F, Rodriguez M: Secondary hyperparathyroidism: Pathogenesis, disease progression, and therapeutic options. Clin J Am Soc Nephrol 6: 913–921, 2011. - PubMed
-
- Ix JH, Isakova T, Larive B, Raphael KL, Raj DS, Cheung AK, Sprague SM, Fried LF, Gassman JJ, Middleton JP, Flessner MF, Block GA, Wolf M: Effects of nicotinamide and lanthanum carbonate on serum phosphate and fibroblast growth factor-23 in CKD: The COMBINE trial. J Am Soc Nephrol 30: 1096–1108, 2019. - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
